Literature DB >> 6291748

Anchorage-independent growth-conferring factor production by rat mammary tumor cells.

J A Zwiebel, M R Davis, E Kohn, D S Salomon, W R Kidwell.   

Abstract

Conditioned medium from cultures of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor cells contain factors that resemble sarcoma growth factor and other transforming growth factors in biological activity but differ in their physical properties. The mammary tumor factors (MTF) are acid stable and heat and protease sensitive. They inhibit the binding of epidermal growth factor, but not insulin, to mouse embryonal carcinoma cells. MTF confers upon normal rat kidney and BALB/c-3T3 cells the ability to grow in soft agar. This effect is enhanced synergistically by high concentrations of fetal calf serum but not by epidermal growth factor. Anchorage-independent growth promotion, however, is not seen with normal mammary epithelial cells, although MTF is mitogenic for these cells as well as normal rat kidney cells, BALB/c-3T3 cells, and chick embryo fibroblasts in monolayer culture, MTF is not mitogenic for primary cultures of the tumor cells from which the factors are derived. Two major molecular weight species of MTF, eluting at Mr 6,000 and 65,000 to 70,000 on Bio-Gel P-100 columns, are present in acid-ethanol extracts of 7,12-dimethylbenz(a)anthracene- and nitrosomethylurea-induced rat mammary tumors. Transplantable tumors derived from primary 7,12-dimethylbenz(a)anthracene- or nitrosomethylurea-induced tumors have little or no MTF activity. These results demonstrate that different chemically induced rat mammary tumors contain transforming growth factor-like activities. Furthermore, it is possible that MTF is unnecessary for the maintenance of tumorigenicity, since some tumors contain no detectable MTF.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291748

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Antiproliferative effect of peripheral benzodiazepine receptor antagonist PK11195 in rat mammary tumor cells.

Authors:  Sutapa Mukhopadhyay; Bobby Guillory; Shyamali Mukherjee; Salil K Das
Journal:  Mol Cell Biochem       Date:  2010-03-04       Impact factor: 3.396

2.  Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression.

Authors:  N T Telang; M P Osborne; L A Sweterlitsch; R Narayanan
Journal:  Cell Regul       Date:  1990-10

Review 3.  EGF-related peptides in the pathophysiology of the mammary gland.

Authors:  N Normanno; F Ciardiello
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

4.  Polyamines and the synthesis of estradiol-regulated growth factors in rat mammary cancer in culture.

Authors:  A Manni; C Wright; G D Luk; G Davis; L M Demers
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

5.  Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.

Authors:  M A Anzano; A B Roberts; J M Smith; M B Sporn; J E De Larco
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells.

Authors:  I Perroteau; D Salomon; M DeBortoli; W Kidwell; P Hazarika; R Pardue; J Dedman; J Tam
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

7.  A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells.

Authors:  Zhengzheng Bao; Mohammad I Malki; Shiva S Forootan; Janet Adamson; Farzad S Forootan; Danqing Chen; Christopher S Foster; Philip S Rudland; Youqiang Ke
Journal:  Genes Cancer       Date:  2013-07

8.  Role of polyamines in the synthesis of prolactin-regulated growth factors by experimental breast cancer in culture.

Authors:  A Manni; B Badger; C Wright; S R Ahmed; S J Santner; G Luk
Journal:  Breast Cancer Res Treat       Date:  1987-11       Impact factor: 4.872

9.  Production and response of a human prostatic cancer line to transforming growth factor-like molecules.

Authors:  A MacDonald; G D Chisholm; F K Habib
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.